A clinical trial has recently been launched to study an investigational medicine for patients with multicentric Castleman's disease (MCD). The study is open to patients in many countries around the world: United States, Canada, Brazil, Russia, UK, Norway, Netherlands, Belgium, Germany, France Spain, Hungary, Egypt, Israel, Taiwan, Korea, Hong Kong, Malaysia, Singapore and Australia. More countries will open for enrollment shortly. More information on this new study can be found at: www.castlemansresearch.com.